Skip to main content

Table 7 Secondary outcomes continued: neuroimaging

From: Study of Mental Activity and Regular Training (SMART) in at risk individuals: A randomised double blind, sham controlled, longitudinal trial

Outcome

Measure

Description

Structural MRI: T1-weighted

Whole Brain Measures

1. Voxel Based Morphometry

A combination of different software packages will be used for automated and semi-automated computational neuroanatomical analyses, in addition to expert manual tracing of hippocampus and entorhinal cortex.

 

2. Cortical thickness

 
 

3. Whole brain volume

 
 

4. GM volume

 
 

5. WM volume

 
 

6. CSF volume

 

Regional Measures

1. Automated regional cortical volume measures

 
 

2. Manually traced subcortical volumes

 

FLAIR-weighted MRI

White matter hyperintensity volume

Automated measure of white matter disease load

Magnetic Resonance Spectroscopy (MRS)

Relative measures of :

1. N-acetylaspartate (NAA)

Measures of different brain metabolites using MR spectroscopy in the hippocampus and posterior cingulate grey matter.

 

2. Cholines

 
 

3. Myo-inositol

 
 

4. Creatine+Phosphocreatine

 

Resting State functional MRI

1. Bilateral hippocampal connectivity

Seed-based correlational analysis and Independent Component Analysis will be used to characterise individuals' resting state BOLD time series.

 

2. Hippocampus functional connectivity map

 
 

3. Posterior cingulate functional connectivity map

 
 

4. Default Mode Network (DMN)

 
 

5. DMN-anticorrelations

Â